PharmaTelevision - Genoma España: The Company's Mission and Biotech Funding in Spain

PharmaTelevision requires Javascript enabled and Adobe Flash Player to watch our programmes. If you do not have Flash installed, you can download it for free from the Adobe Flash homepage.

Improve your Internet experience and start watching exciting new video content.

Video title: Genoma España: The Company's Mission and Biotech Funding in Spain

Visitors: You are watching a 5 minute preview.

Get more information and subscribe now

RSS

Twitter

In This Episode:

Summary
Transcript
Participants
Company

In this episode of PharmaTelevision News Review, Fintan Walton talks with Miguel Vega, Director of Technology Transfer, Genoma España. Filmed at Bio-Europe Spring 2010 in Barcelona, Spain, they discuss:

• The purpose behind Genoma España

• Genoma's need for a dynamic policy and approach to grants

• Eligibility for grants

• How success is measured

• Difficulties that biotechs face in raising funds

Full video transcripts are available with PharmaTelevision Premium Content. Click here to buy a subscription or sign up for a 14 day free trial.

The purpose behind Foundation Genoma Espana .

Fintan Walton:

Hello and welcome to PharmaTelevision News Review here in Barcelona at BioEurope. On this show I have Miguel Vega, who is Director of Technology Transfer at Genoma Espana , welcome to the show.

Miguel Vega:

Thank you for inviting me to the stage.

Fintan Walton:

Well you know Genoma Espana is a government initiative a local Spanish initiative in the national level, what was the purpose of setting up Genoma Espana ?

Miguel Vega:

Well the inception of this national foundation as you said was back in the year 2001. And the main I would say the mission or the main objective in general it was the promotion of biotechnology okay you usually I mean as a biotech institution you can either regulate or promote rather dual role of the lets say the problem and we are just devoted for promoting of biotechnology in Spain.

Fintan Walton:

And you promote that through the provision of grants specifically?

Full video transcripts are available with PharmaTelevision Premium Content. Click here to buy a subscription or sign up for a 14 day free trial.

Miguel Vega

Director of Technology Transfer

Since 2002 Miguel Vega is Head of the Strategic Studies and Innovation Unit at the National Foundation Genoma Espana . He previously held different positions as Head of the Biotechnology Innovation Circle - Regional Government of Madrid; Entrepreneurship and Tech Transfer Director at Madrid Science Park; and Research Grant-holder and Scientific Agent at the Institute for Prospective Technological Studies (IPTS) of the European Commission. B.Sc. & M.Eng. in Agriculture/Food Engineering and PDD (General Manager Programme) at IESE Business School. Among other merits include, Mr. Miguel Vega has been manager of the IP Securitization and Technology Portfolio Programme for Spanish Public Institutions, and couch to more than 25 biotechnology start ups and spin offs from public research institutions. Miguel Vega is author of more than 50 surveys, reports and publications in the field of Biotechnology: Technology watch, foresight, strategic and economic impact studies. He has been responsible for Biotechnology Foresight activities at the National Observatory for Industrial Technology Foresight (OPTI), and coordinator of different expert panels for the design and implementation of National and Regional Strategic Programmes in Biotechnology. Miguel Vega is associated Professor at Universidad Pompeu Fabra, Barcelona, Spain.

Genoma Espana

Genoma Espana is a public foundation whose leading trustee is the Ministry of Science and Innovation, and which mainly focuses on the transfer of intellectual assets, technology, innovation and entrepreneurship, particularly in the biotechnology sector.